The U.S. Food and Drug Administration (FDA) approves weight loss drug lorcaserin, the first such drug approved since 1999.
The U.S. Food and Drug Administration approves the use of aducanumab to treat Alzheimer's disease, the first Alzheimer's drug to be approved in 18 years and the first to target the disease process. The drug is considered controversial as clinical trials gave conflicting results on its effectiveness.
South Africa voluntarily suspends its rollout of the Johnson & Johnson vaccine after the U.S. Food and Drug Administration recommended temporarily suspending use of the vaccine due to rare cases of blood clots.
President Donald Trump and the Food and Drug Administration (FDA) announce the emergency use authorization of convalescent plasma for COVID-19 patients after days of White House officials suggesting there were politically motivated delays by the FDA in approving a vaccine and therapeutics for the disease that President Trump claims has harmed his re-election chances. The FDA said more than 70,000 patients have been treated with convalescent plasma, but they have not yet obtained enough randomized clinical trial data on convalescent plasma for COVID-19. Some of those trials are underway.
The Food and Drug Administration has approved the first treatment that genetically engineers patients' own blood cells to destroy acute lymphoblastic leukemia. The approval makes Novartis the proprietor of the first gene therapy to hit the U.S. market.
The American Medical Association urges Congress and-or the FDA to ban direct-to-consumer advertising of prescription drugs and medical devices. The AMA says that the ads increase demand for inappropriate, expensive treatments even if cheaper ones have the same potentials.
The U.S. Food and Drug Administration approves a new, all-in-one pill to treat HIV patients that includes a new version of the drug tenofovir, which researchers think will help reduce side effects from the multi-drug regimens used for HIV.